EQT to acquire QIAGEN for €10.8 billion in cash deal

QIAGEN N.V. has agreed to an all-cash takeover offer from EQT Private Equity, valued at approximately €10.8 billion. The deal represents a 40.3% premium to QIAGEN's closing price on July 8, 2026, and is subject to shareholder approval at an extraordinary general meeting. The transaction is expected to close in mid-2027, with EQT Private Equity securing committed equity and debt financing.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.